4D MOLECULAR THERAPEUTICS INC. - COMMON STOCK
25.70
10-May-24 14:59:56
15 minutes delayed
Stocks
+0.06
+0.23%
Today's range
24.27 - 26.24
ISIN
N/A
Source
NASDAQ
-
4D Molecular Therapeutics Reports Full Year 2022 Financial Results and Operational Highlights
15 Mar 2023 15:05:01 By Nasdaq GlobeNewswire
-
22 Feb 2023 15:05:00 By Nasdaq GlobeNewswire
-
16 Feb 2023 15:05:00 By Nasdaq GlobeNewswire
-
4D Molecular Therapeutics to Participate in the SVB Securities Global Biopharma Conference
08 Feb 2023 15:05:00 By Nasdaq GlobeNewswire
-
02 Feb 2023 15:05:00 By Nasdaq GlobeNewswire
-
4D Molecular Therapeutics to Participate in the Upcoming Evercore ISI HealthCONx 2022 Conference
21 Nov 2022 15:05:00 By Nasdaq GlobeNewswire
-
14 Nov 2022 06:30:00 By Nasdaq GlobeNewswire
-
10 Nov 2022 15:05:01 By Nasdaq GlobeNewswire
-
4D Molecular Therapeutics Reports Third Quarter 2022 Financial Results
09 Nov 2022 15:05:02 By Nasdaq GlobeNewswire
-
03 Nov 2022 08:45:00 By Nasdaq GlobeNewswire
-
26 Oct 2022 15:05:01 By Nasdaq GlobeNewswire
-
27 Sep 2022 15:10:00 By Nasdaq GlobeNewswire
-
4D Molecular Therapeutics to Participate in Upcoming Investor Conferences
20 Sep 2022 15:15:00 By Nasdaq GlobeNewswire
-
11 Aug 2022 15:03:00 By Nasdaq GlobeNewswire
-
4D Molecular Therapeutics to Participate in Upcoming June Investor Conferences
02 Jun 2022 15:02:00 By Nasdaq GlobeNewswire
-
12 May 2022 15:01:01 By Nasdaq GlobeNewswire
-
4D Molecular Therapeutics to Participate in the BofA Securities 2022 Healthcare Conference
05 May 2022 15:02:00 By Nasdaq GlobeNewswire
-
4D Molecular Therapeutics Reports Full Year 2021 Financial Results and Operational Highlights
28 Mar 2022 15:02:00 By Nasdaq GlobeNewswire
-
22 Feb 2022 15:02:00 By Nasdaq GlobeNewswire